SCHEMBL12884397

SCHEMBL12884397

CC(C)C(C(=O)NCC#N)C(C)(C)C

nearest known ligand 0.53

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CTSS P25774 16/20 0.53
CTSK P43235 15/20 0.53
CTSL P07711 6/20 0.46
CTSB P07858 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12899028 0.82 CTSS (0.54) CTSSCTSKCTSLCTSB
SCHEMBL21266462 0.82 CTSS (0.54) CTSSCTSKCTSLCTSB
SCHEMBL13821721 0.77 CA1 (0.39) CTSSCTSK
SCHEMBL19135317 0.77
SCHEMBL13575661 0.77 CA1 (0.39) CTSSCTSK
SCHEMBL9967749 0.76
SCHEMBL13588554 0.73 USP2 (0.50)
SCHEMBL12884381 0.73 KDM4C (0.41)
SCHEMBL5537815 0.73 USP2 (0.50)
SCHEMBL12884401 0.73 CA1 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110028447-A1 INDAZOLE DERIVATIVES PFIZER INC. 2011-02-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110028447-A1 INDAZOLE DERIVATIVES CNR1, CNR2, GPR119 CTSS 2697/4885CTSK 2324/4885CTSL 4060/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.